New antibiotic tested for safety in patients with weakened kidneys
NCT ID NCT06522945
Summary
This early-stage study tested how a new antibiotic called TQD3524 behaves in the body of people with different levels of kidney function. Researchers gave a single dose to 48 adults with healthy kidneys or with mild to severe kidney disease. The main goal was to measure how the drug moves through and leaves the body, and to check for any safety issues.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTI-RESISTANT GRAM-NEGATIVE BACTERIA CAUSE INFECTION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
The First Affiliated Hospital of Shandong First Medical University (Qianfoshan Hospital)
Jinan, Shandong, 250000, China
Conditions
Explore the condition pages connected to this study.